Skip to main content

and
  1. No Access

    Article

    Double alkylators based conditioning reduced the relapse rate after allogeneic peripheral blood stem cell transplantation in adult patients with myeloid malignancies: a single arm phase II study

    Jie-ling Jiang, Ming Chen, Li-ning Wang, Min Wan in Bone Marrow Transplantation (2022)

  2. Article

    Open Access

    Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide

    Arsenic trioxide [ATO, inorganic arsenite (iAsIII) in solution] plays an important role in the treatment of acute promyelocytic leukemia (APL). However, the long-term adverse effects (AEs) and the retention of ar...

    Yu Zheng, Yuan-Fei Mao, Hui-** Zhao, Li Chen in Experimental Hematology & Oncology (2021)

  3. Article

    Open Access

    Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

    The purpose of the study was to evaluate the feasibility of conditioning regimen with sequential chemotherapy (FLAG-IDA), followed by Fludarabine (5 days) + Busulfan (3 days) by parallel analysis of patients w...

    Ling Wang, Raynier Devillier, Ming Wan, Justine Decroocq in Bone Marrow Transplantation (2019)

  4. Article

    Open Access

    Development and assessment of a predictive nomogram for the progression of IgA nephropathy

    The present study is to establish a nomogram for predicting the prognosis of IgA nephropathy (IgAN). Of the 869 IgAN patients, four-fifths were randomly assigned to the development cohort and one-fifth to the ...

    Lin-lin Liu, Lin-bo Zhu, Jian-nan Zheng, Tong-dan Bi, Jian-fei Ma in Scientific Reports (2018)

  5. No Access

    Article

    Efficacy and Safety of Tacrolimus Versus Cyclophosphamide for Primary Membranous Nephropathy: A Meta-Analysis

    The objective of this systematic review was to compare the efficacy and safety of tacrolimus with cyclophosphamide in primary membranous nephropathy (PMN) patients.

    Lin-bo Zhu, Lin-lin Liu, Li Yao, Li-ning Wang in Drugs (2017)

  6. Article

    Open Access

    Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China

    Serum phosphorus control is critical for chronic kidney disease (CKD) 5D patients. Currently, clinical profile for an oral phosphorus binder in the mainland Chinese population is not available.

    **g Xu, Yi-**ang Zhang, Xue-Qing Yu, Zhi-Hong Liu, Li-Ning Wang in BMC Nephrology (2013)